[1] 方毅敏,陈志成,潘四珍.异烟肼利福平吡嗪酰胺对结核病患者肝功能的影响[J].实用医学杂志,1997;(9):609-610.
[2] Grosset J.Leventis S. Adverse effects of rifampin [J]. Rev Infect Dis,1983,Suppl 3:S440-450.
[3] Altman C,Biour M, Grange JD. Hepatic toxicity of antitubercular agents. Role of different drugs. 1999 cases [J].Presse Med, 1993;22(26):1212-1216.
[4] 王浩.抗结核药所致肝损害防治的进展[J].临床肝胆病杂志,1990;(3):125-126.
[5] Steele MA,Bark RF.Des Prez RM.Toxic hepatitis with isoniazid and rifknpicin.A meta-analysis [J]. Chest, 1991,99:465-471.
[6] Acocella G.Clinical pharmaccddnetics of rifainpicin [J].Clin Pharma-cokinet,1978;3(2):108-110.
[7] Sarraf KA, Michielsen PP, Hauben EI, et al. Hepatotoxicity after a short course of low-dose pyrazinamide [J].Acta Gastroenterol Belg,1996;59(4):251-253.
[8] 邢同京,陈加保,张光曙,等.利福平与异烟肼合用致肝损害的临床与病理分析[J] .中华结核和呼吸杂志,1997;20(1):33-35.
[9] Mizoguchi Y,Sakagami Y, Miyajima K. et al. Experimaital immuno-logical intrahepatic cholestasis model [J].Gastroenterol Jpn, 1988;23(1):18-22.
[10] Kioka K,Mizoguchi Y. Kodama C, et al, Determination of serum chol-estatic factor level by ELISA in drug-induced allergic hepatitis [J].Gastroenterol Jpn, 1988; 23(6):624-628.
[11] Grygorowicz J, Januszko J. Acetylation phenotype and biotransforma-tion of various drngs [J].Wiad Lek 1987;40(5):319-323.
[12] Dossing M, Wilcke JTR, Askgaard DS, et al. Liver injury during anti-tuberculosis treatment:an 11-year study [J].Tuberc Lung Dis,1996,77:335-340.
[13] 郭英江,崔德健.抗结核药所致肝损害[J].中华结核和呼吸杂志.1998;21(5):308-309.
[14] Sodhi CP,Rana SF,Mehta S,et al.Study of oxidtive-stress in rifampi-cin-induced hepatic injury in growing [J].Hum Exp Toxicol, 1997(6):315-321.
[15] Sodhi CP,Rana SF, Attri S,et al. Oxidative-hepatic injury of isoniaz-id-rifanpicin in young rats subjected to protein and energymalmutrition [J].Drug Chem Toxicol 1998;21(3):305-317.
[16] 林钧材,主编.肝脏生物化学[M].北京:人民卫生出版社,1984,14-19.
[17] Davis M,Williams R,“Hepatic disorder” from 《Text book of Adverse Drug Reactions》[M].Davies,DM 4th,ed, 1991.Oxford medical pub-lications. Chapter 11.249-256.
[18] 叶维法,钟振义,主编.肝炎学大典[M].天津:天津科学技术出版社.1996;1156-1371.
[19] 倪根珊,主编.药物临床应用撷萃[M].北京:八一出版社.1994,930-937.
[20] Sama C, Petronelli A, Malavolti M, et al. Double-blind comparative trial of dihydroxydibutylether in patients with choletseiol gallstones [J].Int J Clin Phamiacol Ther Toxicol,1983;21(2):95-97.
|